Drug Patent Expirations for the Week of February 27, 2022

BYDUREON PEN (exenatide synthetic) Astrazeneca ab Patent: 7,223,440 Expiration: Mar 3, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expirations …


New patent expiration for Bayer Hlthcare drug BEYAZ

Annual Drug Patent Expirations for BEYAZ Beyaz is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from two suppliers. There are four patents…
The post New patent expiration for Bayer Hlthcare drug BEYAZ appeared first on D…


Biotechblog